Caitong International Asset Management’s Evommune Inc EVMN Stock Holding History

Caitong International Asset Management’s Portfolio EVMN Stock Details EVMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.84K	Buy	+289	New	+$6.71K	﹤0.01%	1318

Other funds holding EVMN

EFM

EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Andera Partners Paris $206M AUM

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Caitong International Asset Management's EVMN Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Evommune Inc (EVMN) in Q2 2026: 289 shares worth $3.84K. The stake represents ﹤0.01% of the portfolio and ranks #1318 among its holdings.

105 funds tracked by Wall St. Rank hold EVMN as of Q2 2026.

Caitong International Asset Management held 289 shares of Evommune Inc worth $3.84K as of Q2 2026.
Evommune Inc was a new Caitong International Asset Management position in Q2 2026.
Evommune Inc made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1318 holding.
105 funds tracked by Wall St. Rank held Evommune Inc as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.